← Banking With Billy News

Maze Therapeutics said it has completed enrollment in its Phase 2 HORIZON trial in AMKD, marking a key clinical milestone. The company also said it is advancing

BWB News TV • 2026-11-09 21:22 UTC • By Billy Odell Tucker-Robinson
Maze Therapeutics said it has completed enrollment in its Phase 2 HORIZON trial in AMKD, marking a key clinical milestone. The company also said it is advancing
Maze Therapeutics said it has completed enrollment in its Phase 2 HORIZON trial in AMKD, marking a key clinical milestone. The company also said it is advancing MZE782 across PKU and CKD as it builds out its pipeline.
Share this article
𝕏 X / Twitter Facebook LinkedIn WhatsApp
📚 More from Billy’s World
📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly